Description
A selective inhibitor of COX-2 (IC50s = 0.005 and 140 µM for human recombinant COX-2 and COX-1, respectively); decreases LPS-induced production of PGE2 in isolated human whole blood (IC50 = 0.89 µM); reduces carrageenan-induced paw edema and adjuvant-induced arthritis in rats (ED50s = 10.2 and 0.032 mg/kg, respectively)
Formal name: 4-(5-methyl-3-phenyl-4-isoxazolyl)-benzenesulfonamide
Synonyms: SC-65872
Molecular weight: 314.4
CAS: 181695-72-7
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins